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Abstract 
Background. Despite its high prevalence, similar symptoms and
symptom burden, people suffering from chronic heart failure receive
less palliative care than patients with malignant diseases.
Internationally, numerous barriers to palliative care of patients with
chronic heart failure are known, however, there are no credible data
regarding barriers and facilitators to palliative care of people suffering
from chronic heart failure available for Germany.
Design and Methods. Tripartite study. First part of this study evalu-
ates health care providers’ (physicians and nurses) perceived barriers
and facilitators to palliative care of patients with chronic heart failure
using a qualitative approach. At least 18 persons will be interviewed.
In the second part, based on the results of part one, a questionnaire
about barriers and facilitators to palliative care of patients with chron-
ic heart failure will be designed and applied to at least 150 physicians
and nurses. In the last part a classic Delphi method will be used to
develop specific measures to improve the palliative care for chronic
heart failure patients.
Expected Impact for Public Health. The results of this study will help
to understand why patients with heart failure are seldom referred to
palliative care and will provide solutions to overcome these barriers.
Developed solutions will be the first step to improve palliative care in
patients with heart failure in Germany. In addition, the results will
help health care providers in other countries to take action to improve
palliative care situations for heart failure patients.
Background
Chronic heart failure (CHF) is one of the most common diseases of
the cardiovascular system in Germany. Due to our aging population
and the high survival rate after myocardial infarction, an increase in
its prevalence in the coming years and decades has been predicted. In
Germany it is expected that the number of CHF patients older than 80
years will double from a population of 141,000 in 2009 to 353,000 in
2050.1 CHF is the third leading cause of death after chronic ischaemic
heart diseases and myocardial infarctions and is ahead of diseases like
malignant lung, bronchial, breast, and colon cancers.2 The course of
CHF is characterised by worsening symptoms such as dyspnoea, pain,
and fatigue leading to a reduction in daily activities and decreased
quality of life.3 CHF is also a burden to family and friends, especially
when patients’ symptoms and everyday limitations become worse.
Family members can suffer from social isolation, anxiety, insomnia,
depression, and physical exhaustion as well as worries about their
financial situation.4-5
In addition to optimised medical standard of care, palliative care is
known to contribute to improving the situation for CHF patients and
their relatives and its importance has therefore been acknowledged in
national and international guidelines for the management of people
suffering from CHF.6
The WHO defines palliative care as an approach to improve quality
of life, further it is addressed to patients and their families struggling
with problems resulting from a life-threatening disease.7 Through
early detection, accurate diagnoses, the treatment of pain and other
physical, psychological, and psycho-social afflictions, palliative care
concentrates on the prevention and alleviation of suffering and if
required, can be initiated at the time of diagnosis. Studies with small
sample sizes suggest that the palliative care of CHF patients is associ-
ated with decreasing symptom burden and depression and a higher
quality of life,8 as well as greater satisfaction with the treatment, less
need for additional opioids thanks to more effective pain
management,9 and fewer rehospitalisations.10 Moreover, patients and
their relatives consider palliative care as a facilitator to a holistic and
continuous treatment approach which focuses on therapy goals while
offering valuable support in coping with the course and consequences
of the disease. A retrospective analysis of 40,000 patients at a German
university hospital found that heart failure was a significant risk factor
for requiring palliative care (Becker et al., personal communication).
Some CHF patients suffer from severe pain and dyspnoea and can thus
experience symptoms and a symptom burden similar to those of cancer
patients.11 The palliative care of CHF and that of cancer patients dif-
fers in Germany with only up to 6.7% of patients diagnosed with a car-
diovascular disease receiving palliative care in 2013.12
Chronic heart failure patients receiving palliative care suffer more
dyspnoea, are given fewer medications than prescribed, and die alone
more often than cancer patients in palliative care.13 The reasons for
the qualitative and quantitative differences between palliative care of
CHF vs. cancer patients have therefore far received little research
attention. One main reason for the differences might be the course of
heart failure, which is characterised by stages of exacerbation and
relief which makes predicting the right time to initiate palliative care
difficult.14 Furthermore, palliative care is regarded as end-of-life care
even though the WHO recommends its initiation at the time of diagno-
Significance for public health
Patients with chronic heart failure suffer from similar symptoms and symp-
tom burden than patients with malignant diseases. However, palliative care
differs between these groups in a quantitative and qualitative way. This
study will help to understand why patients with chronic heart failure receive
less palliative care than patients with malignant disease. In addition, meas-
ures to overcome barriers and to promote facilitators of palliative care in
patients with chronic heart failure will be developed. These recommenda-
tions could provide a basis for quality improvement projects or studies aim-
ing at improving symptoms and symptom burden of heart failure patients.
The recommended measures could also be used to reduce caregiver burden.
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sis. Other likely barriers to the palliative care of CHF patients are the
lack of knowledge about its features and structures, communication
problems between primary care physicians, cardiologists, and other
healthcare system participants regarding the initiation and manage-
ment of palliative care, difficulty identifying which patients should
receive palliative care, and diverse attitudes on the part of different
professions.15 To the best of our knowledge, there is no credible data
available for Germany regarding physicians’ and nurses’ attitudes
towards palliative care or its barriers and facilitators for CHF patients.
This is the first study to identify barriers and facilitators to palliative
care of CHF patients as perceived by key participants within the health-
care system (physicians and nurses caring for CHF patients) in
Germany, and thereby to develop action plans to improve the situation.
This study’s findings may facilitate future interventions to develop and
expand palliative care for people suffering from CHF and could reduce
their symptom burden as well as the strain on their relatives.
This project will focus on the following research questions: I) Which
attitudes do healthcare system participants (primary care physicians,
resident cardiologists, hospital physicians in the cardiology area, nurs-
es in acute and ambulant areas) hold regarding the palliative care of
people suffering from CHF? II) Which barriers and facilitators do
healthcare system participants perceive regarding the palliative care of
patients with CHF? III) What action plans can be derived from the bar-
riers and facilitators thus identified?
Study design and methodology
Our project is organised in three phases. I) Qualitative study to iden-
tify barriers and facilitators regarding the palliative care of CHF
patients as perceived by physicians and nurses. II) Development of a
questionnaire and survey to assess the perceived barriers and facilita-
tors to palliative care of people suffering from CHF more broadly. III)
Generation of action plans to promote palliative care for CHF patients.
Phase 1 (qualitative study – problem-focusedinterviews)
In the first phase we will assess the barriers, facilitators, personal
theories, and decision-making rules regarding palliative care for CHF
patients as perceived by physicians (hospital physicians, resident car-
diologists, primary care physicians) and nurses (hospital, ambulant
care, heart failure nurses) using qualitative methods of data collection.
We plan to conduct nine guided, problem-centred interviews with each
professional group (overall N=18). The interview guideline will be
developed by applying current knowledge of the topic and will be tested
in one to two interviews and adapted accordingly if required. Once we
have the interviewees’ approval, the interviews will be taped. Their pro-
fessional and biographical background and socio-demographic data will
also be documented. Interviews will be analysed according to Mayring’s
qualitative content analysis.16 Additional interviews will be conducted
if we do not reach data saturation after the first 18 interviews. Data
analysis will be performed within an established qualitative analysis
group to ensure quality criteria like inter-subjective reconstruction.
Those results will be discursively and inductively transferred to an
explanatory model, which will clarify the activities of healthcare system
participants in their dealings with people suffering from CHF.
Interviewees will be recruited by our contacts in each regional office of
the Competence Centre Palliative Care Baden-Wuerttemberg. This com-
petence centre is a network of the four university hospitals in Baden-
Wuerttemberg (Freiburg, Heidelberg, Tubingen, Ulm). The project
members’ professional networks should also be used. Interviews will be
conducted face-to-face or by telephone. Face-to-face interviews are pre-
ferred, as interviewees are usually more open in such a setup.
Telephone interviews will serve to enhance data saturation.
Interviewees for the face-to-face interviews will be recruited from
Freiburg and its environs, which possess a good palliative care infra-
structure. Nevertheless, CHF patients receive too little palliative care
there too, as the investigators can attest. The data analysis should
enable us to identify specific barriers and facilitators to the palliative
care of CHF patients. To guarantee data saturation, physicians and
nurses from other regions will be interviewed as well.
Phase 2 (questionnaire development andsurvey)
A questionnaire derived from the interview results will be developed
and tested in phase 2. This will focus on the following attributes: i) bar-
riers and facilitators to the palliative care of CHF patients; ii) attitudes
toward the palliative care of CHF patients.
Barriers and facilitators are defined as influencing factors that sup-
port or hinder palliative care of CHF patients as perceived or experi-
enced by participants in the healthcare system. The term attitudes
refers to the individual judgements and opinions about the palliative
care of CHF patients held by medical practitioners that can result in
genuine behavioural changes (e.g., setting up palliative care pro-
grams). Statements extracted from the interviews will be grouped and
operationalized. To determine content validity the Content Validity
Index (CVI) will be assessed by consulting specialists in palliative care.
This entails rating the relevance of a central item assessing the con-
struct of interest on a 4-point Likert scale (1 = irrelevant; 4 = very rel-
evant). An item is approved if y of x raters estimates the item as rele-
vant (value 3 to 4 on the Likert scale; Table 1).
To psychometrically test the instrument, a minimum of N=150 physi-
cians and/or nurses will be surveyed online. The following instrument
properties will be checked. 
− Distribution of items: i) analysis of response distribution by deter-
mining number and percentage distribution of responses per item;
ii) analysis of floor- and ceiling effects (given if over 50% of subjects
choose extreme response categories on a Likert scale).
− Scale structure and factorial validity (exploratory factor analysis): i)
to assess which data suit an exploratory factor analysis, the following
values are computed: Kaiser-Meyer-Olkin coefficient should be
>0.60; ii) Bartlett’s sphericity test: this test should be significant;
iii) factor analysis [a) principle component analysis with varimax
rotation; b) factors‘ eigenvalues should be >1].
− Unidimensionality of the resulting scales (confirmatory factor analy-
sis). The following fit indices and critical values will be evaluated: i)
Comparative Fit Index: >0.9: acceptable model fit; >0.95: good model
fit; ii) Tucker-Lewis Index: >0.9: acceptable model fit; >0.95: good
model fit; iii) Root mean square error of approximation: <0.10: mod-
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Table 1. Content Validity Index item approval criteria.
Overall number                         Minimum number (y) of raters
of raters (x)                             to estimate the item as relevant
2-5                                              y=x
6-8                                             y=x−1
9-10                                            y=x−2
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erate model fit; <0.05: good model fit; iv) Standardised root mean
square residual: <0.08.
− Criterion validity (to confirm theoretically-expected relations
between the assessed constructs and external criteria).
− Internal consistency: computation of Cronbach’s Alpha (target value
>0.70) and its 95% confidence interval for scales and subscales.
The results from this project phase will be used to describe partici-
pants’ attitudes and perceived barriers and facilitators. Subgroup
analyses serve to distinguish between occupation and professional
experience. Relevant specialised organisations will be asked whether
they can contact their members by mail to inform them about potential
participation in this study.
Phase 3 (development of action plans)
In phase 3, we will design specific measures to improve the palliative
care for CHF patients in accordance with the results we obtain (thus
evidence-based). These measures will be developed using a classic
Delphi method in three rounds. Ten to 15 heart-failure specialists from
cardiology and palliative care will be invited to participate for this pur-
pose. The Delphi method will be conducted online. In the first round of
the Delphi method, the experts will be presented with the findings from
our project’s phase 2. In reference to those, the experts will propose
measures to support palliative care for people suffering from CHF.
Their proposals will be categorised using content analysis. In round 2
the proposals will be presented to the experts together with recommen-
dations by the project group for agreement. Proposals from the phase-
1 interviewees will also be integrated. Proposals will be evaluated
according to relevance and practicability on an 11-point numeric rating
scale (relevance: 0 = no relevance; 10 = highest relevance; practicabil-
ity: 0 = not practicable; 10 = highly practicable). Means and standard
deviations of experts’ responses will be computed. In round three of the
Delphi method, the experts will be asked to re-evaluate the proposals
while being informed about the means and standard deviations from
the second round as additional evaluation criteria. In so doing, the
experts should reach a consensus on the proposals’ appropriateness
and feasibility. The expert group should ideally consist of physicians
(primary care physicians, resident cardiologist, hospital physicians),
nurses (ambulant care, hospital), and representatives of self-help
groups, health insurers, and palliative care organisations (theory and
practice). The implementation of the activity proposals will not consti-
tute part of this project.
Discussion
Despite the current knowledge from foreign countries about barriers
and facilitators to the palliative care of CHF patients, there are no data
from German-speaking regions (Germany in particular) available. This
study has been designed to contribute to the description of the reality of
palliative care for CHF patients and hence to the development of recom-
mendations for improving therapy structures for CHF patients. The
strength of this study lies especially in the variety of methods we will
apply, as they will enable us to assess individual opinions and experi-
ences of health professionals and also to gather a large pool of quantita-
tive data by conducting a survey. To the best of our knowledge, no Delphi
method has ever been used in this respect. The advantage of this method
is that it will enable palliative care experts to come to a consensus
regarding strategies and recommendations in order to improve the care
situation without being influenced by opinion leaders.
This study’s main challenge will be to find enough interviewees will-
ing to talk openly about their attitudes about the palliative care of CHF
patients. Furthermore, we are wary of the various philosophies, atti-
tudes and interests described in other studies concerning palliative
care – that they will be defended by participants in the healthcare sys-
tem and thus hinder the development of recommendations for improv-
ing the situation for CHF patients. We are well aware that choosing the
experts for the Delphi method will be difficult. It would be worthwhile
considering whether experts from communication research and
healthcare-system research outside the fields of cardiology and pallia-
tive care should eventually be included to ensure an interdisciplinary
approach.
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